NVIEW CORP
15-12G, 1999-09-10
COMPUTER PERIPHERAL EQUIPMENT, NEC
Previous: IMAGYN MEDICAL TECHNOLOGIES INC, 8-K, 1999-09-10
Next: IMMULOGIC PHARMACEUTICAL CORP /DE, SC 13G/A, 1999-09-10




                     U.S. SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                     FORM 15


   CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(G)
            OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF
             DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                 Commission File Number             0-19492

                                nVIEW Corporation
             (Exact Name of registrant as specified in its charter)

          860 Omni Blvd., Newport News, VA 23606; Phone: (757) 873-1354
 (Address, including zip code, and telephone number, including area code,
                  of registrant's principal executive offices)

                                  Common Stock
            (Title of each class of securities covered by this Form)

                                       N/A
         (Titles of all other classes of securities for which a duty to
               file reports under section 13(a) or 15(d) remains)

         Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:

         Rule 12g-4(a)(1)(i)   [X]          Rule 12h-3(b)(1)(ii)   [ ]
         Rule 12g-4(a)(1)(ii)  [ ]          Rule 12h-3(b)(2)(i)    [ ]
         Rule 12g-4(a)(2)(i)   [ ]          Rule 12h-3(b)(2)(ii)   [ ]
         Rule 12g-4(a)(2)(ii)  [ ]          Rule 15d-6             [ ]
         Rule 12h-3(b)(1)(i)   [ ]

         Approximate number of holders of record as of the certification or note
date:

                                       291

         Pursuant to the requirements of the Securities Exchange Act of 1934
nVIEW Corporation has caused this certification/notice to be signed on its
behalf by the undersigned duly authorized person.

DATE:        September 8, 1999           BY:     /s/Jerry W. Stubblefield
      --------------------------------   --------------------------------------
                                                Jerry W. Stubblefield,
                                                Chief Financial Officer
<PAGE>

INSTRUCTION: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the
General Rules and Regulations under the Securities Exchange Act of 1934. The
registrant shall file with the Commission three copies of Form 15, one of which
shall be manually signed. It may be signed by an officer of the registrant, by
counsel or by any other duly authorized person. The name and title of the person
signing the form shall be typed or printed under the signature.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission